Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/baseline-surveillance-in-li-fraumeni-syndrome-using-whole-body-aYle90YSGm
References (31)
-
G Schwarzer (2007)
meta: An R package for meta-analysis -
D. Evans, F. Lennard, L. Pointon, S. Ramus, S. Gayther, N. Sodha, G. Kwan-Lim, M. Leach, R. Warren, D. Thompson, D. Easton, R. Eeles (2009)
Eligibility for Magnetic Resonance Imaging Screening in the United Kingdom: Effect of Strict Selection Criteria and Anonymous DNA Testing on Breast Cancer Incidence in the MARIBS StudyCancer Epidemiology Biomarkers & Prevention, 18
-
A. Villani, A. Shore, J. Wasserman, D. Stephens, R. Kim, H. Druker, Bailey Gallinger, A. Naumer, W. Kohlmann, A. Novokmet, U. Tabori, Marta Tijerin, M. Greer, J. Finlay, J. Schiffman, D. Malkin (2016)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.The Lancet. Oncology, 17 9
-
M. Olivier, R. Eeles, M. Hollstein, Mohammed Khan, C. Harris, P. Hainaut (2002)
The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 19
-
C. Kuhl, S. Schrading, C. Leutner, N. Morakkabati-Spitz, E. Wardelmann, R. Fimmers, W. Kuhn, H. Schild (2005)
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 33
-
(2017)
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Genetic/Familial High Risk Assessment: Breast and Ovarian, Version 2.2017 -
J. Tinat, G. Bougeard, S. Baert-Desurmont, S. Vasseur, Cosette Martin, E. Bouvignies, O. Caron, B. Paillerets, P. Berthet, C. Dugast, C. Bonaïti‐pellié, D. Stoppa-Lyonnet, T. Frebourg (2009)
2009 version of the Chompret criteria for Li Fraumeni syndrome.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 26
-
Chih-Chieh Wu, S. Shete, C. Amos, L. Strong (2006)
Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.Cancer research, 66 16
-
A. Agresti, B. Coull (1998)
Approximate is Better than “Exact” for Interval Estimation of Binomial ProportionsThe American Statistician, 52
-
F. Li, J. Fraumeni (1969)
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?Annals of internal medicine, 71 4
-
S. Saya, E. Killick, Sarah Thomas, N. Taylor, E. Bancroft, J. Rothwell, S. Benafif, A. Dias, C. Mikropoulos, Jenny Pope, A. Chamberlain, R. Gunapala, L. Izatt, L. Side, L. Walker, S. Tomkins, J. Cook, J. Barwell, Vicki Wiles, Lauren Limb, D. Eccles, M. Leach, S. Shanley, F. Gilbert, H. Hanson, D. Gallagher, B. Rajashanker, R. Whitehouse, D. Koh, S. Sohaib, D. Evans, R. Eeles (2017)
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsFamilial Cancer, 16
-
Ruth Dryden, B. Williams, C. McCowan, M. Themessl-Huber (2012)
What do we know about who does and does not attend general health checks? Findings from a narrative scoping reviewBMC Public Health, 12
-
D. Malkin, F. Li, L. Strong, J. Fraumeni, C. Nelson, D. Kim, J. Kassel, M. Gryka, F. Bischoff, M. Tainsky (1990)
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.Science, 250 4985
-
(2016)
A language and environment for statistical computing., R 493 Foundation for Statisical Computing -
R. Dersimonian, R. Dersimonian, N. Laird, N. Laird (1986)
Meta-analysis in clinical trials.Controlled clinical trials, 7 3
-
M. Cheung (2015)
metaSEM: an R package for meta-analysis using structural equation modelingFrontiers in Psychology, 5
-
Gislaine Custódio, Guilherme Parise, Nilton Filho, Heloisa Komechen, C. Sabbaga, R. Rosati, Leila Grisa, I. Parise, M. Pianovski, Carmem Fiori, J. Ledesma, J. Barbosa, F. Figueiredo, Elis Sade, Humberto Ibañez, S. Arram, S. Stinghen, L. Mengarelli, Mirna Figueiredo, Danilo Carvalho, S. Avilla, T. Woiski, L. Poncio, Geneci Lima, R. Pontarolo, E. Lalli, Yinmei Zhou, G. Zambetti, R. Ribeiro, B. Figueiredo (2013)
Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 20
-
G. Bougeard, R. Sesboüé, S. Desurmont, P. Berthet, V. Bonadona, B. Buecher, O. Caron, C. Colas, M. Collonge-Rame, Capucine Delnatte, C. Dugast, J. Fricker, M. Gauthier‐Villars, P. Gesta, P. Jonveaux, C. Lasset, B. Leheup, M. Longy, C. Nogué (2008)
Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS familiesJournal of Medical Genetics, 45
-
K. McBride, M. Ballinger, T. Schlub, M. Young, M. Tattersall, J. Kirk, R. Eeles, E. Killick, L. Walker, S. Shanley, David Thomas, G. Mitchell (2017)
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Familial Cancer, 16
-
G. Bougeard, M. Renaux‐Petel, J. Flaman, C. Charbonnier, Pierre Fermey, Muriel Belotti, M. Gauthier‐Villars, D. Stoppa-Lyonnet, É. Consolino, L. Brugières, O. Caron, P. Benusiglio, B. Paillerets, V. Bonadona, C. Bonaïti‐pellié, J. Tinat, S. Baert-Desurmont, T. Frebourg (2015)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 21
-
A. Chompret, A. Abel, D. Stoppa-Lyonnet, L. Brugières, S. Pagès, J. Feunteun, C. Bonaïti‐pellié (2001)
Sensitivity and predictive value of criteria for p53germline mutation screeningJournal of Medical Genetics, 38
-
A. Chompret, Laurence Brugières, M. Ronsin, M. Gardes, F. Dessarps-Freichey, A. Abel, D. Hua, L. Ligot, Marie-Gabrielle Dondon, B. Paillerets, Thierry Frebourg, Jean Lemerle, Catherine Bonaïti-Pellié, Jean Feunteun (2000)
P53 germline mutations in childhood cancers and cancer risk for carrier individualsBritish Journal of Cancer, 82
-
P. Mai, A. Best, J. Peters, R. Decastro, Payal Khincha, J. Loud, R. Bremer, P. Rosenberg, S. Savage (2016)
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohortCancer, 122
-
J. Peters, R. Kenen, R. Bremer, Shannon Givens, S. Savage, P. Mai (2016)
Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni SyndromeJournal of Genetic Counseling, 25
-
P. Mai, D. Malkin, Judy Garber, Joshua Schiffman, J. Weitzel, Louise Strong, Oliver Wyss, Luana Locke, V. Means, M. Achatz, P. Hainaut, T. Frebourg, D Evans, E. Bleiker, A. Patenaude, K. Schneider, B. Wilfond, June Peters, Paul Hwang, James Ford, U. Tabori, S. Ognjanovic, Phillip Dennis, I. Wentzensen, Mark Greene, J. Fraumeni, Sharon Savage (2012)
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.Cancer genetics, 205 10
-
S. Srivastava, Z. Zou, K. Pirollo, W. Blattner, E. Chang (1990)
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndromeNature, 348
-
A. Chiarelli, Maegan Prummel, D. Muradali, V. Majpruz, M. Horgan, J. Carroll, A. Eisen, W. Meschino, R. Shumak, E. Warner, L. Rabeneck (2014)
Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 21
-
J. Varley (2003)
Germline TP53 mutations and Li‐Fraumeni syndromeHuman Mutation, 21
-
(2013)
eviQ Cancer Treatments Online : Risk 471 Management for adults with a TP 53 mutation -
M. Kriege, C. Brekelmans, I. Obdeijn, C. Boetes, H. Zonderland, S. Muller, T. Kok, R. Manoliu, A. Besnard, M. Tilanus-Linthorst, C. Seynaeve, C. Bartels, R. Kaas, Siebren Meijer, J. Oosterwijk, N. Hoogerbrugge, R. Tollenaar, E. Rutgers, H. Koning, J. Klijn (2006)
Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast CancerBreast Cancer Research and Treatment, 100
-
M. Leach, C. Boggis, A. Dixon, D. Easton, R. Eeles, D. Evans, F. Gilbert, I. Griebsch, R. Hoff, P. Kessar, S. Lakhani, S. Moss, A. Nerurkar, A. Padhani, L. Pointon, D. Thompson, R. Warren (2005)
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)The Lancet, 365
- Publisher
- American Medical Association
- Copyright
- Copyright 2017 American Medical Association. All Rights Reserved.
- ISSN
- 2374-2437
- eISSN
- 2374-2445
- DOI
- 10.1001/jamaoncol.2017.1968
- Publisher site
- See Article on Publisher Site
Abstract
This meta-analysis assesses the clinical utility of whole-body magnetic resonance imaging in 13 cohorts of germline TP53 mutation carriers.
Journal
JAMA Oncology – American Medical Association
Published: Dec 3, 2017